Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Flowers

Showing results (71-80 of 247) with videos related to

Pageof 25
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2015
Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array TestingCecilia C S Yeung, Aaron T Gerds, Min Fang, et al.
JAMA|May 20, 2004
Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphomaKaren L Syrjala, Shelby L Langer, Janet R Abrams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2015
Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation PracticesVeronique Erard, Katherine A Guthrie, Sachiko Seo, et al.
British Journal of Haematology|August 24, 2005
Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-upChristoph Kahl, Wendy Leisenring, H Joachim Deeg, et al.
Bone Marrow Transplantation|January 23, 2008
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimensO Sala-Torra, P J Martin, B Storer, et al.
Blood|March 29, 2003
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantationMarco Mielcarek, Paul J Martin, Wendy Leisenring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2011
Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantationNandita Khera, Barry Storer, Mary E D Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2002
Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemiasMartin Goerner, Theodore Gooley, Mary E D Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2018
Quality of Life of Caregivers of Hematopoietic Cell Transplant RecipientsKareem Jamani, Lynn E Onstad, Merav Bar, et al.
Journal of Cancer Survivorship : Research and Practice|May 6, 2011
Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantationKaren L Syrjala, Allison C Stover, Jean C Yi, et al.
Pageof 25

Showing results (71-80 of 247) with videos related to

Sort By:
Pageof 25
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2015
Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array TestingCecilia C S Yeung, Aaron T Gerds, Min Fang, et al.
JAMA|May 20, 2004
Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphomaKaren L Syrjala, Shelby L Langer, Janet R Abrams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2015
Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation PracticesVeronique Erard, Katherine A Guthrie, Sachiko Seo, et al.
British Journal of Haematology|August 24, 2005
Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-upChristoph Kahl, Wendy Leisenring, H Joachim Deeg, et al.
Bone Marrow Transplantation|January 23, 2008
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimensO Sala-Torra, P J Martin, B Storer, et al.
Blood|March 29, 2003
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantationMarco Mielcarek, Paul J Martin, Wendy Leisenring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2011
Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantationNandita Khera, Barry Storer, Mary E D Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2002
Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemiasMartin Goerner, Theodore Gooley, Mary E D Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2018
Quality of Life of Caregivers of Hematopoietic Cell Transplant RecipientsKareem Jamani, Lynn E Onstad, Merav Bar, et al.
Journal of Cancer Survivorship : Research and Practice|May 6, 2011
Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantationKaren L Syrjala, Allison C Stover, Jean C Yi, et al.
Pageof 25